Daesung Microbiological Labs

036480 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

Daesung Microbiological Labs updated a previously disclosed supply contract with the Public Procurement Service, now worth US$1.19M, about 6.81% of its recent annual revenue, running through Sep 2026.

Supply contract([Amended] Supply contract signed)· FILED 2026-09-30· RCEPT 20260930900583

US$1.19MContract value
6.81%vs. recent revenue
Sep 2026Throughfrom Oct 2025

Converted at 1 USD ≈ ₩1,356.84 (filing-date rate, 2026-09-30 close)

What happened

Daesung Microbiological Labs updated a previously disclosed supply contract with the Public Procurement Service, now worth US$1.19M, about 6.81% of its recent annual revenue, running through Sep 2026.

For context, this single contract equals about 6.81% of the company's most recent annual revenue.

Counterpartythe Public Procurement Service
Contract valueUS$1.19M
vs. recent revenue6.81%
ThroughSep 2026 (from Oct 2025)
Filed2026-09-30, [Amended] Supply contract signed
SourceDART rcept 20260930900583 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-30 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.